{"id":"CHEMBL108","canonicalSmiles":"NC(=O)N1c2ccccc2C=Cc2ccccc21","inchiKey":"FFGPTBGBLSHEPO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CARBAMAZEPINE","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arbil mr","Carbagen sr","Carbamazepine","Carbatrol","Carnexiv","Epimaz","Epimaz ret","Epitol","Equetro","Sirtal ret","Tegretol","Tegretol Xr","Tegretol chewtab","Tegretol prolonged release","Tegretol-xr","Teril","Teril ret","Timonil 200 ret","Timonil 400 ret"],"synonyms":["Biston","Carbamazepine","Carbamazepine anhydrous","Carbamazepine extended release","Carbamazepinum","Finlepsin","G-32883","GEIGY 32883","Karbamazepin","Karbelex","NSC-169864","Neurotol","Neurotop","Sirtal","Stazepine","Tegretal","Telesmin","Timonil"],"crossReferences":{"DailyMed":["carbamazepine"],"PubChem":["11110939","11110940","124879629","144203655","144209471","144210515","170464712","17389547","26751576","50104203","56314829","56422193","855967","90341617"],"TG-GATEs":["18"],"Wikipedia":["Carbamazepine"],"drugbank":["DB00564"],"chEBI":["3387"]},"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0005762","MONDO_0005090","EFO_0002610","EFO_1001219","EFO_0006911","HP_0000726","Orphanet_1956","EFO_0009963","MONDO_0015643","EFO_0004197","HP_0001250","EFO_0000289","EFO_0000474","Orphanet_1945","MONDO_0002050","EFO_0004263","EFO_0000764","MONDO_0004979","MONDO_0007079","EFO_0005230","EFO_0007053"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and has 6 approved and 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1098319","canonicalSmiles":"O=S(=O)(O)CCS","inchiKey":"ZNEWHQLOPFWXOF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MESNA","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mesnex"],"synonyms":["D 7093","Mesna"],"crossReferences":{"DailyMed":["mesna"],"drugbank":["DB09110"],"chEBI":["17905"]},"childChemblIds":["CHEMBL975"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and is indicated for thrombocytopenia and has 49 investigational indications."}
{"id":"CHEMBL1200474","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@H](O)[C@H]3C[C@@H]12.Cl","inchiKey":"GVSJQNRGSCOSNJ-KBHRXELFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEMECLOCYCLINE HYDROCHLORIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1591","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Declomycin","Demeclocycline hydrochloride","Ledermycin"],"synonyms":["Declostatin","Demeclocycline hcl","Demeclocycline hydrochloride","Demethylchlortetracycline hydrochloride","NSC-756708"],"crossReferences":{"DailyMed":["demeclocycline%20hydrochloride"],"PubChem":["144203905","170465205"],"chEBI":["59725"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and is indicated for infection and has 1 investigational indication."}
{"id":"CHEMBL1200601","canonicalSmiles":"CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1.Cl","inchiKey":"AWEZYKMQFAUBTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NARATRIPTAN HYDROCHLORIDE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1278","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amerge","Naramig","Naratriptan"],"synonyms":["GR 85548A","GR-85548A","Naratriptan hcl","Naratriptan hydrochloride"],"crossReferences":{"DailyMed":["naratriptan%20hydrochloride"],"PubChem":["144207166","170465423"],"chEBI":["7479"]},"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546"],"count":2},"linkedDiseases":{"rows":["MONDO_0005277","HP_0012075","EFO_0000677","HP_0002315"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for migraine disorder and has 1 investigational indication."}
{"id":"CHEMBL1200696","canonicalSmiles":"[K+].[O-][Cl+3]([O-])([O-])[O-]","inchiKey":"YLMGFJXSLBMXHK-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM PERCHLORATE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Perchloracap","Peroidin","Pertiroid"],"synonyms":["Potassium perchlorate"],"crossReferences":{"DrugCentral":["4698"],"PubChem":["144212509"],"Wikipedia":["Potassium_perchlorate"],"drugbank":["DB09418"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974 and is indicated for abnormality of the thyroid gland."}
{"id":"CHEMBL1200823","drugType":"Small molecule","blackBoxWarning":false,"name":"IRON SUCROSE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Venofer"],"synonyms":["Ferric hydroxide sucrose complex","Iron oxide saccharated","Iron saccharate","Iron sucrose","Iron sucrose complex","Iron sugar","Iron(iii) hydroxide sucrose complex","Saccharated ferric oxide","Saccharated iron","Saccharated iron oxide","XI-921"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL1200893","canonicalSmiles":"CC(Cc1ccc2c(c1)OCO2)NCC(O)c1ccc(O)c(O)c1.Cl","inchiKey":"LOVXREQUMZKFCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROTOKYLOL HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201273","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ventaire"],"synonyms":["NSC-113490","Protokylol HCl","Protokylol hcl","Protokylol hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201354","canonicalSmiles":"CC[N+](CC)(CC)CCC(O)(c1ccccc1)C1CCCCC1","inchiKey":"NPRHVSBSZMAEIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIDIHEXETHYL","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tridihexethyl","Tridihexethyl cation","Tridihexethyl ion"],"crossReferences":{"Wikipedia":["Tridihexethyl"],"drugbank":["DB00505"],"chEBI":["9701"]},"childChemblIds":["CHEMBL2107686","CHEMBL1200771"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1954 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1201431","drugType":"Enzyme","blackBoxWarning":false,"name":"DORNASE ALFA","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pulmozyme"],"synonyms":["Dornase alfa","Dornase alfa (desoxyribonuclease)","Dornase alfa, rdna","Dornase alfa, recombinant","Dornase alfa,rdna","Dornase alpha","Human dnase-1"],"crossReferences":{"DailyMed":["dornase%20alfa"],"DrugCentral":["5135"]},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for cystic fibrosis and has 18 investigational indications."}
{"id":"CHEMBL1201543","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ZINC SUSP SEMISYNTHETIC PURIFIED HUMAN","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Novolin l"],"synonyms":["Insulin zinc susp semisynthetic purified human"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1983."}
{"id":"CHEMBL1201604","drugType":"Antibody","blackBoxWarning":true,"name":"TOSITUMOMAB","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bexxar"],"synonyms":["Tositumomab"],"crossReferences":{"Wikipedia":["Tositumomab"]},"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0000096","EFO_0000095","EFO_0000574","MONDO_0018906","EFO_1001469","EFO_0005952"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201627","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Insulatard nph human","Novolin n"],"synonyms":["Insulin susp isophane semisynthetic purified human"],"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","HP_0003124","EFO_0001645","HP_0003074","HP_0004326","EFO_0000400","MONDO_0005148","EFO_0000537"],"count":8},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 6 investigational indications."}
{"id":"CHEMBL1201753","canonicalSmiles":"O=C(O)C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1","inchiKey":"VGYFMXBACGZSIL-MCBHFWOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PITAVASTATIN","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Itavastatin","NSC-760423","Pitavastatin"],"crossReferences":{"DailyMed":["pitavastatin%20calcium","pitavastatin%20magnesium"],"Wikipedia":["Pitavastatin"],"drugbank":["DB08860"],"chEBI":["32020"]},"childChemblIds":["CHEMBL3989923","CHEMBL1237061","CHEMBL3989920"],"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","HP_0002140","HP_0003124","EFO_0001645","MONDO_0007254","EFO_0000319","EFO_0004911","Orphanet_309005","EFO_0000537","EFO_0000195","HP_0000083","MONDO_0021187","EFO_0003144","MONDO_0005147","EFO_0003884","Orphanet_79211","HP_0003119","EFO_0007328","EFO_0003918","MONDO_0005148"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 5 approved and 11 investigational indications."}
{"id":"CHEMBL1205969","canonicalSmiles":"O=C(O)CCO","inchiKey":"ALRHLSYJTWAHJZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1205969","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03688"],"chEBI":["33404"]},"childChemblIds":["CHEMBL171409"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1213403","canonicalSmiles":"O=C(O)[C@H]1C[C@H]1C(=O)Nc1cc(F)ccc1F","inchiKey":"QTWGHTBKFVANGX-RQJHMYQMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213403","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07808"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230628","canonicalSmiles":"Nc1nc2c([nH]c(=O)n2[C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]1","inchiKey":"HCAJQHYUCKICQH-VPENINKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230628","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02502"],"chEBI":["40304"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231023","canonicalSmiles":"N[C@H](CP(=O)(O)O)C(=O)O","inchiKey":"LBTABPSJONFLPO-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231023","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11110745","11113385"],"drugbank":["DB03292"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231797","canonicalSmiles":"O=C(Nc1ccc(I)cc1)NC1CCCCC1","inchiKey":"AQTBUVAFYDVTFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231797","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02029"],"chEBI":["41480"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232132","canonicalSmiles":"N[C@@H](Cc1cc(Br)c(O)c(Br)c1)C(=O)O","inchiKey":"COESHZUDRKCEPA-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIBROMOTYROSINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dibromotyrosine"],"crossReferences":{"PubChem":["4254031","50109387","8139944","99494276"],"drugbank":["DB07637"],"chEBI":["28335"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1234524","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](O)C[C@](Oc2ccc3c(C)cc(=O)oc3c2)(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO","inchiKey":"KKDWIUJBUSOPGC-GKHMPSLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234524","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01768"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236196","canonicalSmiles":"CCCC[N+](CCCC)(CCCC)CCCC","inchiKey":"DZLFLBLQUQXARW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRABUTHYLAMMONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tetrabuthylammonium"],"crossReferences":{"drugbank":["DB01851"],"chEBI":["45825"]},"childChemblIds":["CHEMBL60696","CHEMBL1078808","CHEMBL1079205","CHEMBL1079247","CHEMBL1079248","CHEMBL1078938","CHEMBL1077952","CHEMBL1078613","CHEMBL1079159","CHEMBL1078071","CHEMBL1078826","CHEMBL1078233","CHEMBL1078150","CHEMBL2115068","CHEMBL1078326","CHEMBL1078612","CHEMBL1078154","CHEMBL1078234","CHEMBL1077846"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL125381","canonicalSmiles":"Cc1cc(-n2ncc(=O)[nH]c2=O)cc(C)c1Oc1ccc(O)c(C(C)C)c1","inchiKey":"RXQAVKWRCZYGMV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL125381","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03181"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL134342","canonicalSmiles":"O=C(O)CCCC[C@@H]1CCSS1","inchiKey":"AGBQKNBQESQNJD-SSDOTTSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOCTIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tioctic Acid"],"crossReferences":{"PubChem":["29215172","50107042","90340763"],"Wikipedia":["Lipoic_acid"],"drugbank":["DB00166"],"chEBI":["30314"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1551724","canonicalSmiles":"NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1N","inchiKey":"RTRQQBHATOEIAF-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACADESINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acadesine","GP-1-110","NSC-105823"],"crossReferences":{"PubChem":["124893186","144205104","170465608","29217492"],"drugbank":["DB04944"],"chEBI":["28498"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1591","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@H](O)[C@H]3C[C@@H]12","inchiKey":"FMTDIUIBLCQGJB-SEYHBJAFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEMECLOCYCLINE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Demeclocycline","Demethylchlortetracycline"],"crossReferences":{"DailyMed":["demeclocycline%20hydrochloride"],"PubChem":["90341625"],"Wikipedia":["Demeclocycline"],"drugbank":["DB00618"],"chEBI":["4392"]},"childChemblIds":["CHEMBL1200474"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and is indicated for bacterial disease and infection and has 1 investigational indication."}
{"id":"CHEMBL1615374","canonicalSmiles":"Cl.N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1","inchiKey":"RPZBRGFNBNQSOP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VILAZODONE HYDROCHLORIDE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL439849","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Viibryd"],"synonyms":["EMD 68 843","EMD-68843","SB-659746-A","SB659746-A","Vilazodone hcl","Vilazodone hydrochloride"],"crossReferences":{"DailyMed":["vilazodone%20hydrochloride"],"chEBI":["70705"]},"linkedTargets":{"rows":["ENSG00000108576","ENSG00000178394"],"count":2},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0003761","EFO_0001358"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2011 and is indicated for unipolar depression. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1619","canonicalSmiles":"Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1","inchiKey":"PTOAARAWEBMLNO-KVQBGUIXSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLADRIBINE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cladribine","Leustat","Leustatin","Litak","Mavenclad"],"synonyms":["2-cda","Cladaribine","Cladribine","Leustatin","NSC-05014","NSC-105014","NSC-105014-F","RWJ 26251","RWJ-26251"],"crossReferences":{"DailyMed":["cladribine"],"PubChem":["124886798","144204385","144210913","26719669","26757803","50104045","56422184","855756","866156"],"Wikipedia":["Cladribine"],"drugbank":["DB00242"],"chEBI":["567361"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 5 approved and 21 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL16300","canonicalSmiles":"O=C(NO)c1ccccc1","inchiKey":"VDEUYMSGMPQMIK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOHYDROXAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzhydroxamic acid","Benzohydroxamate","N-hydroxybenzamide","benzoyl hydroxamic acid"],"crossReferences":{"PubChem":["124890367","144214021","17388860"],"drugbank":["DB01924"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1651906","canonicalSmiles":"CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"ZSJLQEPLLKMAKR-YDEIVXIUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"STREPTOZOCIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zanosar"],"synonyms":["NSC-37917","NSC-85998","STZ","Streptozocin","Streptozotocin","U-9889"],"crossReferences":{"DailyMed":["streptozocin"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for neoplasm and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1697741","canonicalSmiles":"CCC1=C(C[C@H]2NCCc3cc(OC)c(OC)cc32)C[C@H]2c3cc(OC)c(OC)cc3CCN2C1","inchiKey":"XXLZPUYGHQWHRN-RPBOFIJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEHYDROEMETINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-2,3-dehydroemetine","Dehydroemetine","NSC-131546","RO 1-9334/19","RO-1933419"],"crossReferences":{"drugbank":["DB13865"],"chEBI":["4363"]},"childChemblIds":["CHEMBL1977229"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1698011","canonicalSmiles":"CC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@]12C","inchiKey":"CMRJPMODSSEAPL-FYQPLNBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRENBOLONE ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Finaplix"],"synonyms":["17beta-trenbolone","RU-1697","RU-2341","Trenbolone","Trenbolone acetate","Trenbolone acetate ciii","Trenbolone related compound b","Trienbolone"],"crossReferences":{"PubChem":["144205996","50112693"],"drugbank":["DB14660"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1783282","canonicalSmiles":"CCCNC(=O)c1nnc2c(-c3c(F)cccc3OC)cccc2c1N","inchiKey":"KYDURMHFWXCKMW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD7325","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd7325"],"crossReferences":{"drugbank":["DB13994"]},"linkedTargets":{"rows":["ENSG00000011677","ENSG00000151834"],"count":2},"linkedDiseases":{"rows":["EFO_0003756","EFO_0005230","Orphanet_908"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1788393","canonicalSmiles":"CCOCCN(Cc1ccc(Oc2ccc([N+](=O)[O-])cc2)cc1)C(=O)C(Cl)Cl","inchiKey":"QTRALMGDQMIVFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOFAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethylchlordiphene","Etofamide","Kitnos"],"crossReferences":{"drugbank":["DB13258"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL180570","canonicalSmiles":"O=P(O)(O)CP(=O)(O)O","inchiKey":"MBKDYNNUVRNNRF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEDRONIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Medronate","Medronic acid","Phosphonic acid, methylenebis-","Phosphonic acid, methylenedi-"],"crossReferences":{"PubChem":["144204525","3714055"],"Wikipedia":["Medronic_acid"],"drugbank":["DB14078"],"chEBI":["43945"]},"childChemblIds":["CHEMBL2105165"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1938870","canonicalSmiles":"O=C(O)Cn1nnc(-c2cc(N3CCC(Oc4cc(F)ccc4Br)CC3)no2)n1","inchiKey":"UJEAABFSXKCSGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-8245","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-8245","Mk-8245"],"crossReferences":{"PubChem":["174006769"],"drugbank":["DB13024"]},"childChemblIds":["CHEMBL2153602"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1941138","canonicalSmiles":"C[C@@H](OP(=O)(O)O)C(=O)O","inchiKey":"CSZRNWHGZPKNKY-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R)-2-(Phosphonatooxy)Propanoate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(R)-2-(Phosphonatooxy)Propanoate"],"crossReferences":{"drugbank":["DB01733"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1963502","canonicalSmiles":"C[C@@H](Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1ccccc1","inchiKey":"XRYJULCDUUATMC-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PKI-166","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGP-75166","NVP-PKI166","PKI-166","Pki 166","Pki-166"],"childChemblIds":["CHEMBL1914653"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2001019","canonicalSmiles":"OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1","inchiKey":"PDMUGYOXRHVNMO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04217903","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MET TYROSINE KINASE INHIBITOR PF-04217903","PF-04217903","PF-4217903","Pf-04217903"],"crossReferences":{"PubChem":["103905666","137276005"],"drugbank":["DB12848"]},"childChemblIds":["CHEMBL2170804"],"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2021423","canonicalSmiles":"O=S(=O)([O-])[O-].[Mg+2]","inchiKey":"CSNNHWWHGAXBCP-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM SULFATE ANHYDROUS","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Magnesium Sulfate Anhydrous"],"synonyms":["Magnesium sulfate","Magnesium sulfate anhydrous","Magnesium sulfate, anhydrous","Magnesium sulfate,anhydrous","Magnesium sulphate anhydrous","Magnesium sulphate, anhydrous","Mgso4"],"crossReferences":{"DailyMed":["magnesium%20sulfate"],"drugbank":["DB00653"],"chEBI":["32599"]},"childChemblIds":["CHEMBL3989857"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 8 approved and 53 investigational indications."}
{"id":"CHEMBL202311","canonicalSmiles":"O=c1c2ccccc2oc2ccc(S(=O)(=O)N=c3[nH]nn[nH]3)cc12","inchiKey":"HJWYZPGYPZNDTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL202311","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04698"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL20852","canonicalSmiles":"Nc1cccc(B(O)O)c1","inchiKey":"JMZFEHDNIAQMNB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Aminophenyl Boronic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Aminophenyl Boronic Acid","3-Aminophenylboronic Acid","M-Aminophenylboronic Acid"],"crossReferences":{"PubChem":["26753148"],"drugbank":["DB01896"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104208","canonicalSmiles":"CCC(C)(CC)OC(N)=O","inchiKey":"SLWGJZPKHAXZQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMYLCAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emylcamate","KABI 925","KABI-925","MK-250","NSC-169882"],"crossReferences":{"drugbank":["DB13572"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104309","canonicalSmiles":"CCOC(C(=O)OCCN(C)C)(c1ccccc1)c1ccccc1","inchiKey":"RHUWRJWFHUKVED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMENOXADOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acscn-9617","Dimenoxadol","Dimenoxadole","IDS-ND-011"],"crossReferences":{"PubChem":["170466465"],"drugbank":["DB01461"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106915","canonicalSmiles":"COc1cc2c(cc1OC)C(CCc1ccc(Cl)cc1)N(C)CC2","inchiKey":"YBCPYHQFUMNOJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHOPHOLINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"year":1965},"tradeNames":[],"synonyms":["ARC I-K-1","ARC-I-K-1","Methopholine","Metofoline","Metopholine","NIH 7672","NIH-7672","NSC-169889","RO 4-1778/1","Versidyne"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States  in 1965."}
{"id":"CHEMBL2107723","canonicalSmiles":"COc1cc(O)c(C(=O)Nc2nc(C(=O)NCCN(C(C)C)C(C)C)cs2)cc1OC","inchiKey":"TWHZNAUBXFZMCA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACOTIAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acotiamide"],"crossReferences":{"drugbank":["DB12482"],"chEBI":["34523"]},"childChemblIds":["CHEMBL2107308"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["EFO_0008533"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108506","drugType":"Protein","blackBoxWarning":false,"name":"INTERFERON ALFA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Interf","Roferon-a","Viraferon","Wellferon"],"synonyms":["Interferon alfa","Interferon alfa natural","Interferon alpha"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 44 investigational indications."}
{"id":"CHEMBL2108531","drugType":"Small molecule","blackBoxWarning":false,"name":"POLIFEPROSAN 20","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pcpp-sa (20:80)","Polifeprosan","Polifeprosan 20"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108701","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"HYDROXYETHYL STARCH 130/0.4","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Voluven"],"synonyms":["HES 130/0.4","Hydroxyethyl starch 130/0.4","Volulyte"],"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2108882","drugType":"Antibody","blackBoxWarning":false,"name":"SIBROTUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sibrotuzumab"],"linkedTargets":{"rows":["ENSG00000078098"],"count":1},"linkedDiseases":{"rows":["EFO_0003060"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109323","drugType":"Antibody","blackBoxWarning":false,"name":"IMC-CS4","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMC-CS4","Imc-cs4"],"linkedTargets":{"rows":["ENSG00000182578"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109370","drugType":"Antibody","blackBoxWarning":false,"name":"T84.66","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["T84.66"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109456","drugType":"Antibody","blackBoxWarning":false,"name":"QUILIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANTI-M1","Anti-M1 prime","Anti-M1'","MEMP-1972A","MEMP1972A","MEP-1972A","MEP1972A","Quilizumab","RG-7449"],"linkedTargets":{"rows":["ENSG00000211891"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0005531","MONDO_0004979"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2110367","canonicalSmiles":"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC.COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC.O=S(=O)(O)O","inchiKey":"UILMMYFRNCCPLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHOPRIM SULFATE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL22","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BW 72U","BW-72U","Trimethoprim sulfate","Trimethoprim sulphate"],"crossReferences":{"DailyMed":["trimethoprim%20sulfate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988."}
{"id":"CHEMBL2180602","canonicalSmiles":"CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(F)cc21","inchiKey":"KGSRYTUWXUESJK-FXBPSFAMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAFETINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SIM 010603","SIM-010603","Tafetinib"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL221542","canonicalSmiles":"CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(C)C","inchiKey":"KZJWDPNRJALLNS-VJSFXXLFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETA-SITOSTEROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["b-Sitosterol","beta-Sitosterol"],"crossReferences":{"PubChem":["144205067","73808"],"Wikipedia":["Beta-Sitosterol"],"drugbank":["DB14038"],"chEBI":["27693"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2219421","canonicalSmiles":"O=C(O)c1ccc(/C=C/S(=O)(=O)Cc2ccc(Cl)cc2)cc1","inchiKey":"KBEKQQJUNVQLDZ-MDZDMXLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RECILISIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ex-rad"],"synonyms":["ON 01210","ON 01210.Na","On-01210","Recilisib"],"childChemblIds":["CHEMBL2219410"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL225411","canonicalSmiles":"O=C(NCC1CCOCC1)c1cnc(Nc2ccc(Cl)cc2Cl)nc1C(F)(F)F","inchiKey":"TWQYWUXBZHPIIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW842166X","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW 842166","GW 842166X","GW-842166","GW842166","GW842166X","Gw-842,166x","Gw842166x"],"crossReferences":{"PubChem":["174007169"],"Wikipedia":["GW-842,166X"],"drugbank":["DB11903"]},"linkedTargets":{"rows":["ENSG00000188822"],"count":1},"linkedDiseases":{"rows":["EFO_0004616","EFO_0003843","MONDO_0005178"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2364651","drugType":"Antibody","blackBoxWarning":false,"name":"TOVETUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-575","Tovetumab"],"linkedTargets":{"rows":["ENSG00000134853"],"count":1},"linkedDiseases":{"rows":["EFO_0003060","EFO_0000519","EFO_0000311"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2368925","canonicalSmiles":"O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12","inchiKey":"UKTAZPQNNNJVKR-KJGYPYNMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOLASETRON","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dolasetron"],"crossReferences":{"drugbank":["DB00757"]},"childChemblIds":["CHEMBL2373322","CHEMBL2368924"],"linkedTargets":{"rows":["ENSG00000166736"],"count":1},"linkedDiseases":{"rows":["EFO_0005687","EFO_0006911","HP_0002017","EFO_0004888","EFO_0000311","HP_0002018"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 5 approved and 1 investigational indication."}
{"id":"CHEMBL259833","canonicalSmiles":"Clc1c[nH]c2ncnc(N3CCc4[nH]cnc4C3)c12","inchiKey":"YFFJXGRXFASBDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL259833","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07585"],"chEBI":["90625"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL267178","canonicalSmiles":"COc1ccc(S(=O)(=O)N(Cc2cccnc2)[C@@H](C(=O)NO)C(C)C)cc1","inchiKey":"BSIZUMJRKYHEBR-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CGS-27023A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGS-27023A"],"crossReferences":{"drugbank":["DB07556"]},"childChemblIds":["CHEMBL514138"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL26828","canonicalSmiles":"Ic1ccc2c(c1)CNCC2","inchiKey":"FFCFXJXBXUOFIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL26828","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03824"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL27784","canonicalSmiles":"CC[C@@H](CO)NC(=O)Cc1c(C)n(C(=O)c2ccc(Cl)cc2)c2ccc(OC)cc12","inchiKey":"GKJWXEORYGBJFS-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL27784","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07984"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL279785","canonicalSmiles":"CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C","inchiKey":"OCSMOTCMPXTDND-OUAUKWLOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MARIMASTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BB 2516","BB-2516","GI 5712","GI-5712","KB-R 8898","Marimastat","NSC-719333","TA 2516","TA-2516"],"crossReferences":{"PubChem":["136949642"],"Wikipedia":["Marimastat"],"drugbank":["DB00786"],"chEBI":["50662"]},"linkedTargets":{"rows":["ENSG00000196611","ENSG00000149968","ENSG00000100985","ENSG00000262406","ENSG00000087245","ENSG00000137673"],"count":6},"linkedDiseases":{"rows":["MONDO_0008903","MONDO_0007254"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL281872","canonicalSmiles":"COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1","inchiKey":"YBTGTVGEKMZEQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZD-4190","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ZD-4190"],"childChemblIds":["CHEMBL3544937"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL28636","canonicalSmiles":"COc1ccc(-c2cc(C(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1F","inchiKey":"WAZQAZKAZLXFMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DERACOXIB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Deracoxib","NSC-758935","SC-59046"],"crossReferences":{"PubChem":["144205056","170465679","26749318"],"Wikipedia":["Deracoxib"],"drugbank":["DB11395"],"chEBI":["73032"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL303457","canonicalSmiles":"N#Cc1ccc(NC(=S)NC(=N)Cc2c(Cl)cccc2Cl)cc1","inchiKey":"NWKJBFSBEAMDBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-100943","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-100943"],"crossReferences":{"drugbank":["DB07961"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL31962","canonicalSmiles":"CCCCB(O)O","inchiKey":"QPKFVRWIISEVCW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTYL BORONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butyl Boronic Acid","Butylboronic Acid"],"crossReferences":{"drugbank":["DB02664"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL323202","canonicalSmiles":"N=C(NO)Nc1ccc(Cl)cc1","inchiKey":"JYBXKTLYOMPMQY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL323202","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04559"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3338866","canonicalSmiles":"COc1ccc(CNC(=O)c2cc(-c3cncc(Cl)c3)cnc2-c2ccccn2)nc1OC","inchiKey":"CKTWQGHVNRYNCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-1064","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK 1064","Mk-1064"],"crossReferences":{"drugbank":["DB15028"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL343480","canonicalSmiles":"CC(C)=CCOP(=O)(O)OP(=O)(O)O","inchiKey":"CBIDRCWHNCKSTO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYLALLYL DIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimethylallyl Pyrophosphate"],"crossReferences":{"drugbank":["DB01785"],"chEBI":["16057"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545088","drugType":"Small molecule","blackBoxWarning":false,"name":"PUQUITINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Puquitinib dimesylate","Puquitinib dimesylate dihydrate","Puquitinib mesilate","Puquitinib mesylate","Puquitinib mesylate dihydrate","Xc-302"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545134","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2780301","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ly-2780301"],"linkedTargets":{"rows":["ENSG00000175634","ENSG00000105221","ENSG00000117020","ENSG00000108443","ENSG00000142208"],"count":5},"linkedDiseases":{"rows":["EFO_0000574","EFO_0009708"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545195","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-3009120","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DP-4978","LY3009120","Ly-3009120","Pan-raf inhibitor ly3009120"],"linkedTargets":{"rows":["ENSG00000078061","ENSG00000157764","ENSG00000132155"],"count":3},"linkedDiseases":{"rows":["EFO_0000756","EFO_0004142","EFO_0003060","EFO_0009708"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3545289","canonicalSmiles":"C[C@@H](NC(=O)Cc1c(Cl)ccc(NCC(F)(F)c2cccc[n+]2O)[n+]1O)c1cccc(Cl)c1","inchiKey":"GNYWBETUYIZBHL-CQSZACIVSA-P","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD2207","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd2207"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3678958","canonicalSmiles":"CC(C)n1c(Nc2cccnc2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21","inchiKey":"WSOHOUHPUOAXIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SKLB1028","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sklb1028"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000097007","ENSG00000122025"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000222"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707376","canonicalSmiles":"O=C(O)c1cn(C2CC2)c2cc(N3CCC(O)(COc4ccc(N5C[C@H](CO)OC5=O)cc4F)CC3)c(F)cc2c1=O","inchiKey":"XWFCFMXQTBGXQW-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CADAZOLID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-179811","Cadazolid"],"crossReferences":{"drugbank":["DB11847"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL370805","canonicalSmiles":"COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C","inchiKey":"ZPUCINDJVBIVPJ-LJISPDSOSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"COCAINE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["(r)-(-)-cocaine","Benzoylmethylecgonine","Cocaine","Cocainum","IDS-NC-004","Neurocaine","RX-0041","RX0041"],"crossReferences":{"DailyMed":["cocaine%20hydrochloride"],"drugbank":["DB00907"],"chEBI":["27958"]},"childChemblIds":["CHEMBL529437"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0002610","EFO_0007486","EFO_0005800","MONDO_0005271","EFO_0005611","EFO_0010445"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3833330","drugType":"Antibody","blackBoxWarning":false,"name":"CINPANEMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-054","BIIB054","Biib054","Cinpanemab","Ni-202"],"linkedTargets":{"rows":["ENSG00000145335"],"count":1},"linkedDiseases":{"rows":["MONDO_0005180"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989553","canonicalSmiles":"CS(=O)(=O)O.CS(=O)(=O)O.N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1","inchiKey":"SRXKIZXIRHMPFW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAFAMOSTAT MESYLATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL273264","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FUT-175","Nafamostat dimethanesulfonate","Nafamostat mesilate","Nafamostat mesylate","Ronastat"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3989780","canonicalSmiles":"O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O=S(=O)(OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O)O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O","inchiKey":"WXOMTJVVIMOXJL-BOBFKVMVSA-A","drugType":"Unknown","blackBoxWarning":false,"name":"SUCRALFATE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2367706","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antepsin","Carafate","Sucralfate","Ulcerlmin"],"synonyms":["Aluminum sucrose octasulfate","Citogel","Hexagastron","Succosa","Sucralfate","Sucralfate hydrate","Sucralfin","Sucrate","Sugast","Sulcrate","Ulcar","Ulcermin","Ulcogant","Ulsanic","Urbal","Venter"],"crossReferences":{"DailyMed":["sucralfate"]},"linkedTargets":{"rows":["ENSG00000256713"],"count":1},"linkedDiseases":{"rows":["HP_0004398","EFO_0003948","EFO_0004607"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 3 approved indications."}
{"id":"CHEMBL3989820","canonicalSmiles":"Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1.Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"VXRDAMSNTXUHFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ZOLPIDEM TARTRATE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL911","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ambien","Ambien cr","Edluar","Intermezzo","Stilnoct","Tovalt odt","Zolpidem tartrate","Zolpimist"],"synonyms":["Ivadal","Myslee","Niotal","SL 80.0750-23N","SL-80.0750","SL-80.0750-23N","Stilnox","Tovalt","Zolpidem hemitartrate","Zolpidem tartrate","Zolpidem tartrate civ"],"crossReferences":{"DailyMed":["zolpidem%20tartrate"]},"linkedTargets":{"rows":["ENSG00000113327","ENSG00000163288"],"count":2},"linkedDiseases":{"rows":["EFO_0001073","EFO_0004698"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for insomnia and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989861","canonicalSmiles":"CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1.O.O=C(O)/C=C/C(=O)O","inchiKey":"YETWCSLOYUZBLK-JITBQSAISA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DESVENLAFAXINE FUMARATE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1118","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Desvenlafaxine fumarate","O-desmethylvenlafaxine fumarate"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_0003761"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2013 and is indicated for unipolar depression. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3990045","drugType":"Unknown","blackBoxWarning":false,"name":"TASADENOTUREV","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DNX-2401","Dnx-2401","Tasadenoturev"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL41172","canonicalSmiles":"Oc1cccc(Cl)c1","inchiKey":"HORNXRXVQWOLPJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Chloro-Phenol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Chloro-Phenol","3-Chlorophenol"],"crossReferences":{"PubChem":["144208031","17388933"],"drugbank":["DB01957"],"chEBI":["38855"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL422704","canonicalSmiles":"CCCCCc1cc(O)c2c(c1)OC(C)(CCC=C(C)C)C=C2","inchiKey":"UVOLYTDXHDXWJU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANNABICHROMENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cannabichromene"],"crossReferences":{"Wikipedia":["Cannabichromene"],"drugbank":["DB14735"],"chEBI":["3357"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297328","canonicalSmiles":"O=C(CN1CCOCC1)Nc1ccc(OC2CCN(C3CCC3)CC2)cc1","inchiKey":"LNXDUSQEXVQFGP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUVN-G3031","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SUVN-G3031 FREE BASE","Samelisant","Suvn-g3031"],"crossReferences":{"drugbank":["DB14835"]},"childChemblIds":["CHEMBL4593911"],"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["MONDO_0021107","HP_0100543"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297626","canonicalSmiles":"Cn1nc(C(=O)N(Cc2ccccc2)Cc2ccc(C(=O)O)cc2)c2c1-c1cc(Cl)ccc1OC2","inchiKey":"JYTIXGYXBIBOMN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIDUFEXOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LMB763","Lmb763","Nidufexor"],"linkedTargets":{"rows":["ENSG00000012504"],"count":1},"linkedDiseases":{"rows":["EFO_0003095","EFO_0000401"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297662","canonicalSmiles":"Cn1cnc([N+](=O)[O-])c1C[N+](C)(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(Cl)c(Br)c3)ncnc2cn1.[Br-]","inchiKey":"WAKIMVYUBWMMHJ-FXRZFVDSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TARLOXOTINIB BROMIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4297661","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tarloxotinib bromide"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297752","drugType":"Unknown","blackBoxWarning":false,"name":"FERRIC PYROPHOSPHATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ferric pyrophosphate","Iron (as pyrophosphate)","Iron(iii) pyrophosphate"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298083","drugType":"Protein","blackBoxWarning":false,"name":"BALORAMOTIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Baloramotide","Lage-2, recombinant","Recombinant ny-eso-1 protein"],"description":"Protein drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL444478","canonicalSmiles":"C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO)[C@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"FBSKJMQYURKNSU-ZLSOWSIRSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"ACETOSIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetoside","Acteoside","Verbacoside","Verbascoside"],"crossReferences":{"PubChem":["85201029"],"drugbank":["DB12996"],"chEBI":["9953"]},"description":"Oligosaccharide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594406","drugType":"Small molecule","blackBoxWarning":false,"name":"VIPIVOTIDE TETRAXETAN LUTETIUM LU-177","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4594730","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["177LU-LABELED PSMA-617","177lu-psma-617","Lutetium (177lu) vipivotide tetraxetan","Psma-617 lu-177","Vipivotide tetraxetan lu-177","Vipivotide tetraxetan lutetium lu-177"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL46403","canonicalSmiles":"CCCCCCCCCCCCCCCCCC(=O)O","inchiKey":"QIQXTHQIDYTFRH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STEARIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hystrene 5016"],"synonyms":["Adeka sa 300","Barolub fta","Century 1210","Dervacid 3155","E570","Edenor htict-n","FEMA NO. 3035","Fatty acids, hydrogenated tallow","Hydrofol acid 150","Hydrogenated tallow acid","Hydrogenated tallow acid, beef","Hydrogenated tallow acids","Hydrogenated tallow fatty acids","Hyfac 410","Hyfac 420","Hyfac 421","Hyfac 422","Hystrene 7018","Kolliwax s fine","N-octadecanoic acid","NSC-25956","NSC-261168","Neo-fat 18-57","Neo-fat 18-58","Palmitostearic acid","Prifac 5905","Pristerene 4910","Pristerene 4916","Pristerene 4981","Pristerine 4989","Purified stearic acid","Stearic acid","Stearic acid 50","Stearic acid 70","Sterene 460","Sterene 60b","Sterene 60r","Tallow acid, hydrogenated","Tallow fatty acids, hydrogenated","Tallow, acids, hydrogenated","Tallow, hydrogenated fatty acids"],"crossReferences":{"PubChem":["144204705","144209085","144210879","170465630","17389656","26753067","29216458"],"Wikipedia":["Stearic_acid"],"drugbank":["DB03193"],"chEBI":["28842"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4802233","canonicalSmiles":"O=C(CO)NCCCOc1cccc(CN2CCCCC2)c1","inchiKey":"BCCREUFCSIMJFS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROXATIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Desacetyl-tzu-0460","Roxatidine","Roxit"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL56900","canonicalSmiles":"c1ccc(Cn2c(N3CCNCC3)nc3ccccc32)cc1","inchiKey":"PWWDCRQZITYKDV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LERISETRON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lerisetron"],"crossReferences":{"Wikipedia":["Lerisetron"],"drugbank":["DB12964"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL571","canonicalSmiles":"CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1","inchiKey":"DKYWVDODHFEZIM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"KETOPROFEN","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actron","Alrheumat","Axorid","Fenoket 200","Jomethid xl","Ketocid 200","Ketonal","Ketoprofen","Ketotard 200 xl","Ketovail","Ketozip 200 xl","Larafen","Larafen cr","Nexcede","Orudis","Orudis 100","Orudis kt","Oruvail","Oruvail 100","Oruvail 150","Oruvail 200","Oruvail im","Powergel","Tiloket","Tiloket cr","Valket 200 retard"],"synonyms":["(rs)-ketoprofen","19583RP","Actron ketoprofen","Aneol","Capisten","Hydratropic acid, m-benzoyl-","IDEA-033","Iso-k","Ketoprofen","Ketorin","NSC-758144","R.P. 19,583","R.P. 19583","RP-19583","RU-4733","Sector"],"crossReferences":{"DailyMed":["ketoprofen"],"PubChem":["11532908","144204145","144208045","170465449","26747548","50086520","50106498","85231099","857801","90341309"],"Wikipedia":["Ketoprofen"],"drugbank":["DB01009"],"chEBI":["6128"]},"childChemblIds":["CHEMBL4650345","CHEMBL341922"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","EFO_0002970","EFO_0000685","MONDO_0002009","HP_0011110","Orphanet_79383","EFO_0003843","EFO_0005755","HP_0011868","HP_0002829","MONDO_0005277","EFO_1001412","MP_0001845","EFO_0000546","HP_0003326","EFO_0000512","MONDO_0002471","EFO_0009582","EFO_0000649","EFO_0004253","EFO_0004888","EFO_0004616","HP_0003419","HP_0100607","MONDO_0002258","MONDO_0005178","MONDO_0004857"],"count":27},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 7 approved and 14 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL576960","canonicalSmiles":"COc1cc(-c2cc(C)cc(C)c2)cc([C@@H](C)C#Cc2c(C)nc(N)nc2N)c1","inchiKey":"ATFDKOLABYIYCC-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL576960","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07142"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL601719","canonicalSmiles":"C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl","inchiKey":"KTEIFNKAUNYNJU-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CRIZOTINIB","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xalkori"],"synonyms":["Crizotinib","NSC-756645","PF-02341066","PF-2341066","Pf-2341066"],"crossReferences":{"DailyMed":["crizotinib"],"Wikipedia":["Crizotinib"],"drugbank":["DB08865"],"chEBI":["64310"]},"linkedTargets":{"rows":["ENSG00000171094","ENSG00000181163","ENSG00000105976","ENSG00000143924"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003086","EFO_1000616","EFO_0000571","EFO_0000403","MONDO_0007254","EFO_0000222","EFO_0000228","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_1001951","EFO_1000026","EFO_0000640","MONDO_0001056","EFO_0003032","MONDO_0008903","MONDO_0011962","EFO_0000574","EFO_0001378","MONDO_0015798","EFO_0000707","MONDO_0024880","Orphanet_637","EFO_0000519"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 4 approved and 18 investigational indications."}
{"id":"CHEMBL607048","canonicalSmiles":"COCC[C@H]1CC2CN3CCc4c([nH]c5ccccc45)[C@](C(=O)OC)(C2)[C@H]13","inchiKey":"DTJQBBHYRQYDEG-JNBMDGLNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"18-METHOXYCORONARIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-18-methoxycoronaridine","18-methoxycoronaridine"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL627","canonicalSmiles":"C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21","inchiKey":"ZPMKQFOGINQDAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMITRIPTYLINOXIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMITRYPTYLINE-N-OXIDE","Ambivalon","Amitriptyline oxide","Amitriptyline-n-oxide","Amitriptylinoxide","Equilibrin","J9.621K"],"crossReferences":{"PubChem":["4253961"],"Wikipedia":["Amitriptylinoxide"],"drugbank":["DB13114"]},"childChemblIds":["CHEMBL1994889"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL63859","canonicalSmiles":"OCC(CO)(CO)NCCCNC(CO)(CO)CO","inchiKey":"HHKZCCWKTZRCCL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL63859","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Bis-tris_propane"],"drugbank":["DB02676"],"chEBI":["40947"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL7863","canonicalSmiles":"C=CCC1(C(C)C)C(=O)NC(=O)NC1=O","inchiKey":"UORJNBVJVRLXMQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APROBARBITAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Alurate"],"synonyms":["Allypropymal","Aprobarbital","NSC-120769"],"crossReferences":{"Wikipedia":["Aprobarbital"],"drugbank":["DB01352"],"chEBI":["2791"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL82324","canonicalSmiles":"O=C(O)c1ccc(B(O)O)cc1","inchiKey":"SIAVMDKGVRXFAX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Boronobenzoic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Boronobenzoic Acid","4-Carboxyphenylboronicacid","4-Dihydroxyboranyl-Benzoic Acid Anion","4-Phenylester Boronic Acid"],"crossReferences":{"PubChem":["26753149"],"drugbank":["DB03140"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL837","canonicalSmiles":"CCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC","inchiKey":"FJHBVJOVLFPMQE-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"7-ETHYL-10-HYDROXYCAMPTOTHECIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7-Ethyl-10-Hydroxy-Camptothecin","7-ethyl-10-hydroxycamptothecin","IT-141","Irinotecan related compound b","It-141","NK 012","NK-012","NK012","Nk012","SN 38","SN-38"],"crossReferences":{"PubChem":["515301"],"Wikipedia":["SN-38"],"drugbank":["DB05482"],"chEBI":["8988"]},"linkedTargets":{"rows":["ENSG00000198900"],"count":1},"linkedDiseases":{"rows":["EFO_1001480","MONDO_0008903","MONDO_0007254","EFO_0000702","EFO_0000311","EFO_1001951"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL844","canonicalSmiles":"Brc1c(NC2=NCCN2)ccc2nccnc12","inchiKey":"XYLJNLCSTIOKRM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRIMONIDINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AGN-190342 FREE BASE","Brimonidine","NSC-318825","UK-14304","UK-1430418 FREE BASE"],"crossReferences":{"DailyMed":["brimonidine%20tartrate"],"PubChem":["104171261","11111939","11113354","144203850","170464941","26751556","50104157","85231282","855898","90340645"],"Wikipedia":["Brimonidine"],"drugbank":["DB00484"],"chEBI":["3175"]},"childChemblIds":["CHEMBL1200389","CHEMBL2062257"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["MONDO_0001330","EFO_0004190","EFO_1001069","HP_0010783","EFO_1000879","EFO_0001365","EFO_1000906","EFO_0003770","MONDO_0008315","HP_0031284","EFO_0000537","Orphanet_791","EFO_0009606","EFO_1000760","EFO_1001022","EFO_0005240","MONDO_0021698","MONDO_0005301","EFO_0007141","EFO_0005751","EFO_0000516","EFO_1001893","EFO_0003822"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 7 approved and 13 investigational indications."}
{"id":"CHEMBL85398","canonicalSmiles":"O=C1CSC(=O)N1","inchiKey":"ZOBPZXTWZATXDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIAZOLIDINEDIONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thiazolidine-2,4-Dione","Thiazolidinedione"],"crossReferences":{"drugbank":["DB11898"],"chEBI":["50992"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL870","canonicalSmiles":"NCCCC(O)(P(=O)(O)O)P(=O)(O)O","inchiKey":"OGSPWJRAVKPPFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALENDRONIC ACID","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Binosto","Fosamax"],"synonyms":["Alendronate","Alendronic Acid","Alendronic acid","Fosamax"],"crossReferences":{"DailyMed":["alendronate%20sodium"],"Wikipedia":["Alendronic_acid"],"drugbank":["DB00630"],"chEBI":["2567"]},"childChemblIds":["CHEMBL675","CHEMBL2367465"],"linkedTargets":{"rows":["ENSG00000160752"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0004261","EFO_0011061","EFO_0003869","Orphanet_93276","HP_0004349","MONDO_0008170","MONDO_0007254","EFO_0003762","EFO_0000266","EFO_0004260","EFO_0004197","HP_0003418","EFO_0003882","Orphanet_666","HP_0000938","EFO_0000589","MONDO_0002050","EFO_0008506","EFO_0003854","EFO_0000649","EFO_0000764","EFO_0000673","MONDO_0004979","EFO_1000882","EFO_0004259","MONDO_0005178"],"count":27},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 5 approved and 17 investigational indications."}
{"id":"CHEMBL87385","canonicalSmiles":"OCCN1CCN(CC/C=C2\\c3ccccc3Sc3ccc(Cl)cc32)CC1","inchiKey":"WFPIAZLQTJBIFN-BLLMUTORSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOPENTHIXOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AY-62021","Chlorpenthixol","Clopenthixol","N-746","NSC-64087","Sordinol"],"crossReferences":{"PubChem":["11112430"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL980","canonicalSmiles":"COc1ccccc1OCC(O)CO","inchiKey":"HSRJKNPTNIJEKV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUAIFENESIN","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amonidron","Famel","Franolyn chesty","Gecolate","Glycerol Guaiacolate","Guaifenesin","Guaiphenesin","Liqufruta","Mucinex","Nirolex for chesty cough decongestant","Robitussin","Tixylix chesty cough"],"synonyms":["CVT-2534","Glyceryl guaiacolate","Guaiacol glyceryl ether","Guaifenesin","Guaifensin","Guaiphenesin","Humabid","Hustosil","Methphenoxydiol","NSC-62112","Robitussin"],"crossReferences":{"DailyMed":["guaifenesin"],"PubChem":["11532912","144212411","170464855","26748064"],"Wikipedia":["Guaifenesin"],"drugbank":["DB00874"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 4 approved and 3 investigational indications."}
